Use of PC-SPES, a commercially available supplement for prostate cancer, in a patient with hormone-naive disease
- 1 August 1999
- Vol. 54 (2) , 319-323
- https://doi.org/10.1016/s0090-4295(99)00216-2
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Clinical and Biologic Activity of an Estrogenic Herbal Combination (PC-SPES) in Prostate CancerNew England Journal of Medicine, 1998
- Estrogen and Progestin Bioactivity of Foods, Herbs, and SpicesExperimental Biology and Medicine, 1998
- Experience with low‐dose oestrogen in the treatment of advanced prostate cancer: a personal viewBritish Journal of Urology, 1996
- Double-blind, randomized study of primary hormonal treatment of stage D2 prostate carcinoma: flutamide versus diethylstilbestrol.Journal of Clinical Oncology, 1996
- Human prostatic steroid 5α-reductase isoforms—A comparative study of selective inhibitorsThe Journal of Steroid Biochemistry and Molecular Biology, 1995
- Inhibition of the activity of ‘basic’ 5α-reductase (type 1) detected in DU 145 cells and expressed in insect cellsThe Journal of Steroid Biochemistry and Molecular Biology, 1994
- Body-sodium and Blood Volume in a Patient with Licorice-induced HypertensionJournal Of Hypertension, 1985
- Treatment of Prostatic Cancer: Effects on Serum Lipoproteins and the Cardiovascular SystemJournal of Urology, 1985
- Leuprolide versus Diethylstilbestrol for Metastatic Prostate CancerNew England Journal of Medicine, 1984
- Effect of eating liquorice on the renin-angiotensin aldosterone axis in normal subjects.BMJ, 1977